Publications

1995

Lin J, Yon RW, Chavin KD, Qin L, Woodward J, Ding Y, et al. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2. Transplantation. 1995;59(8):1162-71.
Wang H, Rodgers WH, Chmell MJ, Svitek C, Schwartz HS. Osteosarcoma oncogene expression detected by in situ hybridization. J Orthop Res. 1995;13(5):671-8.
Choudhri SH, Brownstone R, Hashem F, Magro CM, Crowson AN. A case of necrotizing fasciitis due to Streptococcus pneumoniae. Br J Dermatol. 1995;133(1):128-31.
Hirschman SA, Hoda SA, May M, Cody HS. Intraductal carcinoma in a male breast: diagnosis by nipple discharge cytology. Diagn Cytopathol. 1995;12(4):354-6.
Symmans WF, Liu J, Knowles DM, Inghirami G. Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions. Hum Pathol. 1995;26(2):210-6.
Sanz L, Moscat J, Diaz-Meco MT. Molecular characterization of a novel transcription factor that controls stromelysin expression. Mol Cell Biol. 1995;15(6):3164-70.
Chadburn A, Suciu-Foca N, Cesarman E, Reed E, Michler RE, Knowles DM. Post-transplantation lymphoproliferative disorders arising in solid organ transplant recipients are usually of recipient origin. Am J Pathol. 1995;147(6):1862-70.
Kastrinakis WV, Ramchurren N, Rieger KM, Hess DT, Loda M, Steele G, et al. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene. 1995;11(4):647-52.
Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85(2):552-65.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700